Next Article in Journal
Assessment of Pulmonary Arterial Hypertension by Magnetic Resonance Imaging
Previous Article in Journal
Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications
 
 
Tomography is published by MDPI from Volume 7 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Grapho, LLC.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Positron Emission Tomography in Prostate Cancer: Summary of Systematic Reviews and Meta-Analyses

Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California, 2250 Alcazar Street, CSC 102, Los Angeles, CA 90033, USA
Tomography 2015, 1(1), 18-22; https://doi.org/10.18383/j.tom.2015.00130
Submission received: 3 June 2015 / Revised: 6 July 2015 / Accepted: 7 August 2015 / Published: 1 September 2015

Abstract

Prostate cancer is a prevalent public health problem worldwide. Over the past decade, there has been tremendous research activity in the potential use of positron emission tomography with a number of radiotracers targeted to various biological aspects of this complex tumor. Systematic reviews and meta-analyses are important contributions to the relevant literature that summarize the evidence while reducing the effect of various sources of bias in the published data. The accumulation of relevant data in this clinical setting has recently provided the opportunity for systematic reviews. In this brief article, I summarize the published systematic reviews and meta-analyses of positron emission tomography in prostate cancer. Most robust evidence suggests a probable role for first-line use of positron emission tomography with radiolabeled choline in restating patients with biochemical relapse of prostate cancer with the diagnostic performance that seems to be positively associated with the serum prostate-specific antigen level and velocity. Future systematic reviews will be needed for other emerging radiotracers such as those based on the prostate-specific membrane antigen and gastrin-releasing peptide receptor.
Keywords: prostate; cancer; positron emission tomography; meta-analysis prostate; cancer; positron emission tomography; meta-analysis

Share and Cite

MDPI and ACS Style

Jadvar, H. Positron Emission Tomography in Prostate Cancer: Summary of Systematic Reviews and Meta-Analyses. Tomography 2015, 1, 18-22. https://doi.org/10.18383/j.tom.2015.00130

AMA Style

Jadvar H. Positron Emission Tomography in Prostate Cancer: Summary of Systematic Reviews and Meta-Analyses. Tomography. 2015; 1(1):18-22. https://doi.org/10.18383/j.tom.2015.00130

Chicago/Turabian Style

Jadvar, Hossein. 2015. "Positron Emission Tomography in Prostate Cancer: Summary of Systematic Reviews and Meta-Analyses" Tomography 1, no. 1: 18-22. https://doi.org/10.18383/j.tom.2015.00130

Article Metrics

Back to TopTop